Loading institutional data...
Loading institutional data...
Insufficient data to determine institutional momentum.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Top 1 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
How management deployed cash over 10 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Reinvestment has been productive — operating income grew well per dollar put in. Current ROIC on all capital: 45%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $30M covers all $2M of scheduled principal — no refinancing pressure. Scheduled principal only (excludes interest & revolver draws). As of 2020-03-31 (10-K).
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Interest is easily covered by operating profit.
Cash vs short-term debt unavailable.
Short-term / long-term split not separately reported.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Solve the discounted cash flow backwards, then stress-test the assumptions.
To be worth $0.25 today, the market must believe free cash flow compounds 5.3%/yr for a decade (off $14M normalized FCF).
The market's 5.3% is more conservative than its 5-yr track record.
2-stage DCF · 1.08B shares · net debt -$30M
mean 87.1% · volatility σ 217% · implied rate exceeded in 2/3 yrs
Central path = implied 5.3%/yr growth; shaded band = ±1σ (217%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
6/8 of the 9 checks — 1 couldn't be scored (see above), so the score is out of the 8 with data.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Cash conversion lags reported earnings — watch accruals. Lower/negative accruals = higher quality (Sloan).
Comfortably covers interest.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $0 buybacks = $0 returned on $23M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
No trend data available for this metric.
EOD close · as of 2026-09-17
How a revenue dollar becomes profit — FY2026
Each value shows its share of revenue below it (common-size).
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $148.9M 100.0% | $84.0M 100.0% | $56.6M 100.0% | $34.2M 100.0% | $32.3M 100.0% | $25.4M 100.0% | $18.0M 100.0% | $7.6M 100.0% | $7.5M 100.0% | $9.6M 100.0% |
| Cost of Revenue | $73.8M 49.6% | $44.0M 52.3% | $30.3M 53.5% | $17.6M 51.4% | $17.5M 54.1% | $13.5M 53.2% | $10.0M 55.7% | $4.7M 62.1% | $3.5M 47.1% | $5.9M 61.2% |
| Gross Profit | $75.0M 50.4% | $40.1M 47.7% | $26.4M 46.5% | $16.6M 48.6% | $14.8M 45.9% | $11.9M 46.8% | $8.0M 44.3% | $2.9M 37.9% | $3.9M 52.9% | $3.7M 38.8% |
| Research & Development | $5.7M 3.9% | $8.0M 9.5% | $6.9M 12.2% | $6.2M 18.2% | $4.1M 12.6% | $5.1M 20.1% | $5.5M 30.7% | $7.6M 100.4% | $9.6M 129.0% | $8.3M 86.1% |
| Selling, General & Admin | $17.6M 11.8% | $9.0M 10.7% | $7.1M 12.6% | $5.1M 15.0% | $4.5M 13.8% | $3.3M 13.1% | $3.3M 18.6% | $3.1M 40.7% | $2.3M 31.3% | $2.1M 21.6% |
| Total Operating Expenses | $25.9M 17.4% | $20.5M 24.4% | $15.6M 27.5% | $12.9M 37.8% | $9.7M 30.1% | $9.8M 38.5% | $10.3M 57.0% | $12.0M 158.9% | $13.0M 174.3% | $11.1M 115.1% |
| Operating Income | $49.1M 33.0% | $19.6M 23.3% | $10.8M 19.1% | $3.7M 10.8% | $5.1M 15.7% | $2.1M 8.3% | -$2.3M -12.7% | -$9.2M -121.0% | -$9.1M -121.4% | -$7.4M -76.3% |
| Interest Expense | $111K 0.1% | $128K 0.2% | $589K 1.0% | $1.1M 3.3% | $192K 0.6% | $260K 1.0% | $356K 2.0% | $369K 4.9% | $335K 4.5% | $238K 2.5% |
| Interest & Investment Income | $208K 0.1% | $21K 0.0% | $21K 0.0% | $7K 0.0% | $126 0.0% | $514 0.0% | $12K 0.1% | $21K 0.3% | $18K 0.2% | $13K 0.1% |
| Other Income (Expense), net | $7.7M 5.2% | -$19.7M -23.4% | -$10.3M -18.2% | $310K 0.9% | $1.2M 3.8% | $2.0M 8.0% | $47K 0.3% | -$797K -10.5% | $4.3M 58.1% | $9.3M 96.5% |
| Pretax Income | $56.8M 38.2% | -$52K -0.1% | $463K 0.8% | $4.0M 11.7% | $6.3M 19.5% | $4.1M 16.3% | -$2.2M -12.4% | -$10.0M -131.5% | -$4.7M -63.3% | $1.9M 20.2% |
| Income Tax Expense | $11.9M 8.0% | $4.3M 5.1% | -$19.6M -34.7% | $424K 1.2% | -$1.7M -5.4% | — | — | -$676K -8.9% | -$1.0M -14.0% | -$1.9M -19.4% |
| Net Income | $44.9M 30.1% | -$4.3M -5.1% | $20.1M 35.5% | $3.6M 10.4% | $8.9M 27.6% | $5.1M 20.0% | -$2.2M -12.5% | -$9.3M -122.6% | -$3.7M -49.2% | $3.8M 39.5% |
| Per Share | ||||||||||
| EPS (Basic) | $0.04 | $0.00 | $0.02 | $0.00 | $0.01 | $0.01 | $0.00 | $-0.01 | $0.00 | $0.03 |
| EPS (Diluted) | $0.03 | $0.00 | $0.02 | $0.00 | $0.01 | $0.00 | $0.00 | $-0.01 | $-0.01 | $-0.01 |
| Weighted Avg Shares (Basic) | 1.07B | 1.07B | 1.02B | 1.01B | 1.01B | 943.0M | 832.3M | 814.2M | 796.1M | 838.7M |
| Weighted Avg Shares (Diluted) | 1.14B | 1.07B | 1.02B | 1.01B | 1.01B | 943.0M | 993.3M | 816.3M | 798.2M | 844.5M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
EOD close · as of 2026-09-17
No material risks flagged.
Where each multiple sits in its own 15-yr range · 34th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 15-yr history.
Is the profit real, and how strong is the balance sheet?
FY2026 · every deduction from revenue to net income
DuPont — the three levers
Returns are margin-driven, not leverage-driven — higher quality.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
High operating leverage: profit moved 2.0× as fast as sales — great in an upturn, painful in a downturn.
Each line as % of revenue — the trend in color
| % of revenue | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 62.1 | 55.7 | 53.2 | 54.1 | 51.4 | 53.5 | 52.3 | 49.6 |
| Gross Profit | 37.9 | 44.3 | 46.8 | 45.9 | 48.6 | 46.5 | 47.7 | 50.4 |
| R&D | 100.4 | 30.7 | 20.1 | 12.6 | 18.2 | 12.2 | 9.5 | 3.9 |
| SG&A | 40.7 | 18.6 | 13.1 | 13.8 | 15.0 | 12.6 | 10.7 | 11.8 |
| Operating Income | -121.0 | -12.7 | 8.3 | 15.7 | 10.8 | 19.1 | 23.3 | 33.0 |
| Income Tax | -8.9 | — | — | -5.4 | 1.2 | -34.7 | 5.1 | 8.0 |
| Net Income | -122.6 | -12.5 | 20.0 | 27.6 | 10.4 | 35.5 | -5.1 | 30.1 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on ELTP: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Ranked against 1085 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BCAX | $1.24T | — | — | — | — | — | — | -34.4% | -34.4% | — | 143 |
| LLY | $1.03T | 50.2× | — | 15.9× | 44.7% | 83.0% | 31.7% | 77.8% | 29.9% | — | 4,193 |
| AKTX | $894.1B | — | — | — | — | — | — | -61.1% | -61.1% | — | 1 |
| JNJ | $650.5B | 24.5× | — | 6.9× | 6.0% | 67.9% | 28.5% | 32.9% | 20.7% | — | 4,451 |
| ABBV | $467.1B | 111.9× | 33.4× | 7.6× | 8.6% | 70.2% | 6.9% | -129% | 6.6% | 4.2× | 3,895 |
| MRK | $368.2B | 20.2× | — | 5.7× | 1.3% | 74.8% | 28.1% | 34.7% | 17.9% | — | 3,594 |
| UNH | $339.9B | 28.4× | 19.7× | 0.8× | 11.8% | 88.7% | 2.7% | 12.0% | 6.8% | 3.9× | 2,891 |
| AZN | $257.7B | — | — | — | — | — | — | — | — | — | 1,248 |
| TMO | $248.2B | 37.1× | 31.9× | 5.6× | 3.9% | — | 15.0% | 12.6% | 7.0% | 4.9× | 2,481 |
| AMGN | $204.6B | 26.7× | 17.6× | 5.6× | 10.0% | 67.2% | 21.0% | 89.1% | 12.2% | 3.8× | 3,014 |
| GILD | $187.3B | 22.3× | 20.4× | 6.4× | 2.4% | 78.8% | 28.9% | 37.5% | 17.9% | 2.4× | 2,218 |
| ABT | $178.0B | 27.5× | 19.2× | 4.0× | 5.7% | 56.4% | 14.7% | 12.5% | 10.0% | 1.4× | 2,964 |
| PFE | $157.1B | 20.3× | — | 2.5× | -1.6% | 74.3% | 12.4% | 9.0% | 5.1% | — | 2,838 |
| DHR | $150.2B | 42.1× | 31.0× | 6.1× | 2.9% | 59.1% | 14.7% | 6.9% | 5.1% | 3.4× | 2,083 |
| ISRG | $136.2B | 48.7× | 37.5× | 13.5× | 20.5% | 66.0% | 28.4% | 16.0% | 16.0% | — | 2,190 |
| VRTX | $131.1B | 33.7× | 28.8× | 10.9× | 8.9% | 86.2% | 32.9% | 21.2% | 21.2% | — | 1,609 |
| BMY | $127.8B | 18.2× | — | 2.6× | -0.2% | 71.1% | 14.6% | 38.2% | 11.1% | — | 2,431 |
| MDT | $118.8B | 24.9× | 12.6× | 3.3× | 8.4% | 65.0% | 13.2% | 9.7% | 9.4% | 0.2× | 2,114 |
| CVS | $114.7B | 64.9× | 11.5× | 0.3× | 7.8% | 45.0% | 0.4% | 2.4% | 2.4% | 0.0× | 1,795 |
| SYK | $107.1B | 33.4× | 18.4× | 4.3× | 11.2% | 64.0% | 12.9% | 14.5% | 8.5% | 2.5× | 2,196 |
| MCK | $102.5B | 22.9× | 16.2× | 0.3× | 12.4% | 3.6% | 1.2% | -219% | 109% | 1.0× | 1,946 |
| HCA | $96.4B | 15.1× | — | 1.3× | 7.1% | — | 9.0% | -113% | 16.8% | — | 1,346 |
| ELV | $91.4B | 16.4× | 15.5× | 0.5× | 12.5% | 89.4% | 2.8% | 12.9% | 7.6% | 4.2× | 1,397 |
| REGN | $82.6B | 19.0× | 19.8× | 5.8× | 1.0% | — | 31.4% | 14.4% | 13.6% | 0.5× | 1,336 |
| CI | $72.7B | 12.4× | 5.5× | 0.3× | 11.2% | 21.8% | 2.2% | 14.3% | 14.1% | 0.0× | 1,583 |
| ELTP | $269M | 8.3× | 4.8× | 1.8× | 77.1% | 50.4% | 30.1% | 45.4% | 45.4% | — | 1 |
Peers = companies sharing ELTP's sector (Healthcare) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.